Stemetil (Prochlorperazine) Dosing for Nausea and Vomiting
For nausea and vomiting in adults, the standard dose of Stemetil (prochlorperazine) is 5-10 mg orally 3-4 times daily, with a maximum of 40 mg per day. 1
Standard Adult Dosing
- Begin with 5 mg or 10 mg orally 3-4 times daily for severe nausea and vomiting 1
- Daily doses above 40 mg should only be used in resistant cases 1
- Dosage should be adjusted based on individual response, starting with the lowest recommended dose 1
Context-Specific Recommendations
For Chemotherapy-Induced Nausea (Low Emetogenic Risk)
- Prochlorperazine 10 mg orally every 6 hours as needed is recommended for low emetogenic chemotherapy agents 2
- May be combined with dexamethasone 20 mg orally for enhanced effect 2
- Can be used with or without lorazepam and with or without H2 blockers or proton pump inhibitors 2
For Opioid-Induced Nausea
- Prochlorperazine 5-10 mg orally 3-4 times daily can be used as first-line prophylaxis when initiating opioid therapy 3
- If nausea persists despite as-needed dosing, switch to scheduled around-the-clock administration for 1 week, then return to as-needed dosing 3
Special Population Considerations
Elderly Patients
- Use lower doses within the recommended range as elderly patients are more susceptible to hypotension and neuromuscular reactions 1
- Dosage should be increased more gradually and patients observed closely 1
Debilitated or Emaciated Patients
- Dosage should be increased more gradually in these populations 1
Critical Safety Warnings
Extrapyramidal Symptoms Risk
- Monitor closely for dystonic reactions and akathisia, which can occur within the first week of treatment 2, 4
- The incidence of extrapyramidal symptoms with prochlorperazine is approximately 14% 4
- Diphenhydramine can be used to treat dystonic reactions if they occur 2
- Benztropine may be used in patients allergic to diphenhydramine 2
Tardive Dyskinesia Risk
- Long-term use carries risk of tardive dyskinesia, a potentially irreversible movement disorder 5
- Consider alternative antiemetics (ondansetron, granisetron) for prolonged treatment to avoid this risk 5
Regarding the Ptosis
The right eye ptosis mentioned in your clinical context is unrelated to prochlorperazine dosing for nausea. If the ptosis is related to myasthenia gravis, topical oxymetazoline hydrochloride 0.1% has shown efficacy in temporarily eliminating myasthenic ptosis for up to 7 hours 6. However, this is a separate therapeutic consideration from antiemetic management and should be addressed through appropriate neuromuscular or ophthalmologic consultation 2.
Common Pitfalls to Avoid
- Do not use prochlorperazine in children under 20 pounds or under 2 years of age 1
- Do not exceed 40 mg daily in routine cases without clear justification for resistant symptoms 1
- Avoid prolonged use without reassessing the need, given tardive dyskinesia risk 5
- When converting from liquid to crushed tablet formulations, doses may not be equivalent and require adjustment 7